| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eaedb2b5507f37bb604493995f5df2ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8844c5d6b41b20eeaf5b5044e12a5c7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-906
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-963 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
1996-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7183bc57340b534389669640da20ead9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0846de8ff0c63242c29fa8e5fa080c52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffe00bfea5b8e8aad50840d6326fab01 |
| publicationDate |
1998-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H1045601-A |
| titleOfInvention |
Antiviral material |
| abstract |
(57) [Summary] The object of the present invention is to provide a virus infection preventive agent which is previously applied to mucosal tissues or the like to prevent virus infection and suppresses virus invasion, and to remove viruses existing in solution or air. An object of the present invention is to provide fine particles, filters, or virus killers that can be safely and easily removed or inactivated. The anti-viral material comprises a mannose-binding lectin bonded to a substrate comprising a hydrophobic polymer chain via a hydrophilic polymer chain, and the hydrophilic polymer chain has a water absorption of 2% or more. And an antiviral material having a hydrophobic polymer chain having a water absorption of 2% or less. In addition, the antiviral material is in the form of fine particles having a diameter of 100 nm to 1 mm or a filter structure having a pore diameter of 100 nm to 10 μm. |
| priorityDate |
1996-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |